FDA board investigates Depo-Provera safety.
D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D003906:Developing Countries; D005193:Family Planning Services; D006077:Government Agencies; D017258:Medroxyprogesterone Acetate; D009656:North America; D009938:Organizations; D011057:Politics; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Contraception; Contraceptive Agents, Female--standards; Contraceptive Agents, Progestin--standards; Contraceptive Agents--standards; Depo-provera--standards; Developed Countries; Developing Countries; Family Planning; Government Agencies; Medroxyprogesterone Acetate--standards; North America; Northern America; Organizations; Political Factors; United States